SCHEDULE 13G/A: BlackRock Amends Semler Scientific Stake Disclosure to 4.3%

Sentiment:

Beneficial Ownership Disclosure


BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.3% beneficial ownership stake in Semler Scientific Inc. common stock.

Summary

  • BlackRock, Inc. reported beneficial ownership of 632,370 shares of Semler Scientific Inc. common stock.
  • This represents 4.3% of the class of securities.
  • BlackRock, Inc. holds sole voting power over 617,932 shares and sole dispositive power over 632,370 shares.
  • No shared voting or dispositive power was reported.
  • The filing is an Amendment No. 1 to a Schedule 13G, indicating a previous filing.
  • One or more BlackRock subsidiaries beneficially own 5% or greater of the outstanding shares of Semler Scientific Inc.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

NA

Management Comments

  • To the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

This filing is a standard disclosure of institutional ownership, reflecting BlackRock's passive investment in Semler Scientific Inc. It does not provide broader industry trends or competitive analysis.

Stakeholder Impact

  • Shareholders: Provides transparency regarding a significant institutional investor's stake in the company.

Key Dates

DateDescription
2025-01-21Date of execution of the Power of Attorney by BlackRock, Inc.
2025-06-30Date of event which requires filing of this statement.
2025-07-16Signature date of the Schedule 13G filing by BlackRock, Inc.

Keywords

BlackRock, Semler Scientific, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.